Equities

SKAN Group AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SKAN Group AG

Actions
  • Price (CHF)59.68
  • Today's Change0.00 / 0.00%
  • Shares traded79.00
  • 1 Year change--
  • Beta0.8551
Data delayed at least 15 minutes, as of Jan 22 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

  • Revenue in CHF (TTM)332.13m
  • Net income in CHF16.18m
  • Incorporated2001
  • Employees1.50k
  • Location
    SKAN Group AGKreuzstrasse 5ALLSCHWIL 4123SwitzerlandCHE
  • Phone+41 432683232
  • Fax+41 313801859
  • Websitehttps://skan.com/de/home/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SKAN:SWX since
announced
Transaction
value
ABC Transfer SASDeal completed31 Jul 202531 Jul 2025Deal completed-26.25%--
Data delayed at least 15 minutes, as of Feb 10 2026 12:03 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.